Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Leverone Jason A.
Chief Financial Officer at OnKure Therapeutics. Filing since 4 Apr 2025.
CIK 0001692747
Company
Date
Role
Action
Shares
Amount
Of holding
OKUR
OnKure Therapeutics, Inc.
21 Sep 2026
Chief Financial Officer
Sold at will
302
$898.21
1.6%
OKUR
OnKure Therapeutics, Inc.
22 Jun 2026
Chief Financial Officer
Sold at will
303
$1.33K
1.6%
OKUR
OnKure Therapeutics, Inc.
23 Mar 2026
Chief Financial Officer
Sold at will
301
$1.25K
1.8%
OKUR
OnKure Therapeutics, Inc.
22 Dec 2025
Chief Financial Officer
Sold at will
302
$896.25
1.8%
OKUR
OnKure Therapeutics, Inc.
22 Sep 2025
Chief Financial Officer
Sold at will
303
$794.92
2.3%
OKUR
OnKure Therapeutics, Inc.
23 Jun 2025
Chief Financial Officer
Sold at will
303
$722.41
2.3%
OKUR
OnKure Therapeutics, Inc.
7 Apr 2025
Chief Financial Officer
Sold at will
1,844
$4.93K
12.3%
OKUR
OnKure Therapeutics, Inc.
4 Apr 2025
Chief Financial Officer
Sold at will
1,278
$4.25K
7.8%
8 decisions on file.
